Managing Cancer Grand Challenges funding

Founders' logos

This page is for researchers funded through Cancer Grand Challenges, prospective and current applicants for funding, and their host institutions. Relevant contractual documentation and guidance for managing Cancer Grand Challenges funding can be found at the bottom of this page.

Key documents

When receiving Cancer Grand Challenges funding, all investigators and institutions participating in a team are required to sign up to a Cancer Grand Challenges Award Agreement, also signed by the research funders: Cancer Research UK and the National Cancer Institute (NCI).

The Award Agreement incorporates the terms outlined in the Award Management and Funding Policy Guide, Commercialisation Policy and National Cancer Institute Other Transaction Award Policy Guide. You can access all of these documents below, as well as the Cancer Research UK Allowable Costs Guidance.

Each funded institution will also be subject to specific terms detailed in their Notice of Award and Grant Award Letter. All contractual documents may be updated from time to time, and the most up-to-date versions will be posted here.

Cancer Grand Challenges Award Agreement:

This is the lead contracting document to be signed by all parties within a team. The Award Agreement linked above is a template; funded researchers should refer to their own populated and executed Agreement. Please contact [email protected] if you aren’t able to locate this.

Award Management & Funding Policy Guide

This document is a guide to the management of Cancer Grand Challenges awards starting in 2022 and beyond.

Commercialisation Policy

This document outlines the commercialisation process entered into by all parties

Cancer Research UK Allowable Costs Guidance

This document provides teams with information about items that can be charged to the Cancer Research UK portion of Cancer Grand Challenges funding.

NCI Cancer Grand Challenges Other Transaction Award Policy Guide

NCI will issue Cancer Grand Challenges awards to Institutions using the NIH Other Transaction (OT) Authority, granted under Section 402(n) of the Public Health Service Act. This document outlines terms specific to this.